Volume | 41,979 |
|
|||||
News | - | ||||||
Day High | 25.44 | Low High |
|||||
Day Low | 25.00 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Protagonist Therapeutics Inc | PTGX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
25.25 | 25.00 | 25.44 | 25.56 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
1,035 | 41,979 | US$ 25.25 | US$ 1,060,078 | - | 13.72 - 33.34 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
09:31:38 | 100 | US$ 25.075 | USD |
Protagonist Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.48B | 58.27M | - | 60M | -78.96M | -1.35 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Protagonist Therapeutics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTGX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 26.71 | 27.78 | 24.22 | 25.45 | 449,056 | -1.64 | -6.12% |
1 Month | 27.74 | 29.21 | 24.22 | 26.92 | 527,783 | -2.67 | -9.61% |
3 Months | 26.00 | 33.34 | 24.22 | 28.20 | 574,535 | -0.925 | -3.56% |
6 Months | 14.38 | 33.34 | 13.76 | 24.22 | 700,112 | 10.70 | 74.37% |
1 Year | 22.60 | 33.34 | 13.72 | 23.08 | 803,441 | 2.48 | 10.95% |
3 Years | 29.46 | 50.54 | 6.91 | 21.02 | 983,109 | -4.39 | -14.88% |
5 Years | 10.32 | 50.54 | 4.47 | 19.78 | 762,787 | 14.76 | 142.97% |
Protagonist Therapeutics Description
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment. |